文献速递血脂与心血管预防

辅助生殖技术使用后母亲的心血管疾病风险

Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies.
PubMed 文献 · JAMA Cardiol · 2023-01-01

中位随访11年期间,ART组与未使用ART组相比心血管疾病风险无升高(AHR 0.97;95%CI 0.91-1.02),心肌梗死风险呈轻度降低趋势(AHR 0.80;95%CI 0.65-0.99)。

要点

  • ART分娩女性中位随访11年心血管疾病风险未升高(AHR 0.97;95%CI 0.91-1.02)
  • 缺血性心脏病、脑血管病、卒中、心肌病、心衰、肺栓塞、深静脉血栓风险均无显著差异
  • 心肌梗死风险呈轻度降低趋势(AHR 0.80;95%CI 0.65-0.99),国家间无异质性

核心结论

  • 与未使用ART受孕者相比,ART分娩女性在中位11年随访中心血管疾病风险未增加。
  • 仍需更长期研究进一步评估ART是否与更高心血管疾病风险相关。

研究设计与样本

  • 基于丹麦(1994-2014)、芬兰(1990-2014)、挪威(1984-2015)、瑞典(1985-2015)全国登记数据的队列研究。
  • 采用Cox比例风险回归,校正年龄、随访开始日历年、产次、多囊卵巢综合征诊断、糖尿病、慢性高血压和国家。

主要发现

  • 中位随访11年(IQR 5-18),任何心血管疾病发生率为153/10万人年。
  • 未使用ART女性平均(SD)年龄29.1(4.9)岁,使用ART者33.8(4.7)岁。
  • 缺血性心脏病、脑血管病、卒中、心肌病、心力衰竭、肺栓塞、深静脉血栓风险均无显著差异。
  • 心肌梗死风险呈轻度降低趋势(AHR 0.80;95%CI 0.65-0.99),国家间无明显异质性。

临床怎么用

  • 对经ART分娩的女性,现有证据不支持将其心血管疾病风险单独上调,可按常规心血管风险评估管理。

局限性

  • 中位随访仅11年,不足以评估更长期的心血管结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The use of assisted reproductive technologies (ARTs) is steadily increasing worldwide. The outcomes associated with treatment for an individual's long-term health, including risk of cardiovascular disease (CVD), remain largely unknown, due to the small number of studies and their limited follow-up time. OBJECTIVE: To study whether the risk of CVD is increased among individuals who have given birth after ART compared with those who have given birth without ART. DESIGN, SETTING, AND PARTICIPANTS: A registry-based cohort study was conducted using nationwide data from Denmark (1994-2014), Finland (1990-2014), Norway (1984-2015), and Sweden (1985-2015). Data analysis was conducted from January to August 2022. A total of 2 496 441 individuals with a registered delivery in the national birth registries during the study period were included, and 97 474 (4%) of these gave birth after ART. EXPOSURES: Data on ART conception were available from ART quality registries and/or medical birth registries. MAIN OUTCOMES AND MEASURES: Information on CVD was available from patient and cause of death registries. The risk of CVD was estimated with Cox proportional hazards regression, adjusting for age, calendar year of start of follow-up, parity, diagnosis of polycystic ovary syndrome, diabetes, chronic hypertension, and country. RESULTS: Median follow-up was 11 (IQR, 5-18) years. The mean (SD) age of women with no use of ART was 29.1 (4.9) years, and the age of those who used ART was 33.8 (4.7) years. The rate of any CVD was 153 per 100 000 person-years. Individuals who gave birth after using ART had no increased risk of CVD (adjusted hazard ratio [AHR], 0.97; 95% CI, 0.91-1.02), with evidence of heterogeneity between the countries (I2 = 76%; P = .01 for heterogeneity). No significant differences in the risk of ischemic heart disease, cerebrovascular disease, stroke, cardiomyopathy, heart failure, pulmonary embolism, or deep vein thrombosis were noted with use of ART. However, there was a tendency for a modest reduction in the risk of myocardial infarction (AHR, 0.80; 95% CI, 0.65-0.99), with no notable heterogeneity between countries. CONCLUSIONS AND RELEVANCE: The findings of this study suggest that women who gave birth after ART were not at increased risk of CVD over a median follow-up of 11 years compared with those who conceived without ART. Longer-term studies are needed to further examine whether ART is associated with higher risk of CVD.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Magnus MC, Fraser A, Håberg SE, et al. Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies. JAMA Cardiol. 2023. PMID: 37556134. doi:10.1001/jamacardio.2023.2324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。